Polarized Raman spectroscopy has been used to obtain the room-temperature phonon spectra of the series of rare earth orthovanadate single crystals: SmVO4, HoVO4, YbVO4, and LuVO4. The observed Raman frequencies follow the overall mode distribution expected for REVO4 compounds with the tetragonal zircon structure. The variation of the mode frequency with atomic number across the lanthanide orthovanadate series was investigated, and the trend exhibited by the internal modes was explained by considering the force constants of VO4 tetrahedron.
Pressure-dependent Raman scattering studies in the range 0.0 -32 kbar were carried out in L-alanine in order to investigate its external mode phonon spectra in relation to the phase transitions in the crystal. A careful analysis of the spectra shows that the low-energy Raman modes exhibit variation both in frequency and in intensity and between 26 and 28 kbar it is observed a splitting of a external mode, indicating that the D 2 normal phase undergoes a transition. Pressure coefficients for external modes are also given.
Raman scattering is used to investigate the room temperature phonons of tetragonal (I4∕m) Sr2CoWO6 and monoclinic (P21∕n) Ca2CoWO6, Sr2CoTeO6, and Ca2CoTeO6 double perovskites. Both tetragonal and monoclinic structures result from small distortions of the Fm3¯m cubic lattice. Therefore, phonons were assigned according to correlations with those observed in the prototype A2B′B″O6 Fm3¯m cubic structure and the internal vibrational modes of the oxygen octahedra. The observed shifts of some vibrations in the A2CoBO6 compounds upon changing either A or B elements are tentatively explained.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.